May 8, 2008

Pharmaceutical litigation is one of the most rapidly expanding areas of law for plaintiff attorneys.

The AAJ Exchange offers numerous pharmaceutical Litigation Packets, including the newly updated Pharmaceutical Products Liability Cases, SSRIs and the Link to Suicide, and Duragesic Fentanyl Pain Patch, as well as Hormone Therapy, Gadolinium, Avandia, Ortho Evra, Kugel Mesh, Oxycontin, and others.

The newly updated Pharmaceutical Products Liability Cases addresses and contains materials on the FDA prescription drug approval process and its inherent flaws; drug companies’ direct-to-consumer marketing tactics and the effect on the learned intermediary doctrine; promotion of off-label use by drug companies and the adverse effects; pharmacology; epidemiology and its role in proving causation; theories of liability; recent trends in pharmaceutical liability cases; sample complaints, client intake forms and drug intake and evaluation forms; and strategies and case law on avoiding preemption.  

SSRIs and the Link to Suicide, Duragesic Fentanyl Pain Patch and other pharmaceuticalproducts liabilityLitigation Packets provide an array of valuable tools and resources and include court documents such as complaints, written discovery, motions and memoranda, and orders; deposition transcripts and summaries; FDA materials relating to product approval, labeling changes and adverse events; AAJ Education speaker papers, similar matters and other secondary resources.

In light of ongoing litigation in these areas, members are encouraged to frequently search the Exchange for new and updated materials. For more information on these and other pharmaceutical products liability packets please visit the AAJ Exchange at www.justice.org/exchange and select “Litigation Packets” or call the Exchange at 800-344-3023.